ArticleFrontiers in veterinary science2025
Development of a self-assessment/benchmarking tool for regulators of veterinary medicines.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The regulation of veterinary medicines is important for animal health and welfare, for human health, for sustainable food production, and for minimising impacts on the environment. The capability to regulate these medicines is therefore also important to provide confidence to stakeholders, particularly the public. Although there is a Global Benchmarking Tool to assess the capability of regulatory bodies for human medicines, developed by the World Health Organisation (WHO), the veterinary regulatory sector lacks a similar global, comprehensive scheme and associated guidance. A review of schemes that address veterinary medicines regulatory bodies was undertaken and compared to the WHO scheme to develop a proposed scheme for regulators of veterinary medicines. This new tool will provide a comprehensive and systematic approach to strengthening regulatory systems, fostering harmonisation, and ensuring the quality, safety, and efficacy of veterinary medicinal products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.